Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

Avicenna Oncology

 

Presenter:

Zaki Sellam, CEO

 

About:

Avicenna Oncology GmbH is a biotechnology start-up, created in 2014 in Basel, Switzerland, with a lead preclinical stage immuno-oncology program named ImmunoPayloads (ImPs). ImPs are First In Class therapeutics with the ability to activate highly potent and specific T cell CD4+ cytotoxic memory response against B cell neoplasm.